Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
University: University of Glasgow
Sector(s): Life Sciences
In the western world, colorectal cancer is now the third most frequent cancer and the second most common cause of cancer deaths. In the US nearly 150,000 new cases are being diagnosed each year and more than 56,000 people died from the disease in 2002. In the UK, around 15,000 people die from the disease each year.
Current screening techniques are notoriously inaccurate, leading to many false positives which saturate resources available for follow-up diagnosis. But scientists at the University of Glasgow have pioneered a new sensor technology, Lab-in-a-Pill, that could have major impact on the cost and effectiveness of bowel cancer treatment. At the core of Lab-in-a-Pill is a miniaturised sensor, processing and communications module all enclosed in a chemical-resistant capsule which currently measures around 3cm x 1cm in prototype form. This sensor wirelessly transmits data to a receiver pack worn on the outside of the body. The device has been taken to laboratory-scale. Prototyping of devices and in-vivo trials remain to be completed.
The IP associated with this technology is owned by the University of Glasgow.
Easy Access Documents:
Please enter your name.
Please enter the name of the company you work for.
Is your company an SME?
Please select the country you are in.
Please enter your email address.
Please enter your telephone number.
To help us process your enquiry faster please enter some details about the information you are interested in.
Please prove you are a human by completing this simple image recognition task.
The University of Glasgow has developed Soluble Polymer Catalysts, using organocatalysts for chiral chemical production...
University of Glasgow scientists have borrowed techniques employed in the semi-conductor industry to pattern the surfaces of either hard or soft materials and render these surfaces less adhesive to cells.
The Thermoelectric Sensor technology is a Nano-Calorimetric Sensor which measures very small changes in temperature. The IP provides a route to making the most sensitive calorimetric measurements (with a resolution of 0.1 mK).
The University of Glasgow is offering an exciting new model for the evaluation of new treatments for Parkinsons disease
The technology, developed at the University of Aberdeen, relates to the MRI system which will cost significantly less than current equipment. Most existing magnetic resonance imagers are highly sophisticated, occupy a large amount of space and are costly to purchase and maintain. There are numerous...